Shopping Cart
- Remove All
- Your shopping cart is currently empty
Sovesudil (PHP-201) is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor, showing IC50 values of 3.7 nM for ROCK-I and 2.3 nM for ROCK-II, and capable of lowering intraocular pressure (IOP) without inducing hyperemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,900 | 8-10 weeks | |
50 mg | $2,480 | 8-10 weeks | |
100 mg | $3,890 | 8-10 weeks |
Description | Sovesudil (PHP-201) is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor, showing IC50 values of 3.7 nM for ROCK-I and 2.3 nM for ROCK-II, and capable of lowering intraocular pressure (IOP) without inducing hyperemia. |
In vitro | Sovesudil (PHP-201) at a concentration of 1 μM, when administered for 60 minutes, can induce changes in the behavior of human trabecular meshwork (HTM) cells [1]. |
In vivo | Sovesudil, at concentrations of 0.1%, 0.3%, and 0.5%, administered to male New Zealand White rabbits, effectively lowers Intraocular Pressure (IOP) in both normotensive and acute hypertensive conditions without inducing significant hyperemia [1]. |
Molecular Weight | 407.44 |
Formula | C23H22FN3O3 |
Cas No. | 1333400-14-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.